Speaker Profile
Aydogan Ozcan

Aydogan Ozcan PhD

Healthcare Technology, Bioinformatics
Los Angeles, California, United States of America

Connect with the speaker?

Dr. Ozcan is the Chancellor’s Professor at UCLA and an HHMI Professor with the Howard Hughes Medical Institute, leading the Bio- and Nano-Photonics Laboratory at UCLA Electrical Engineering and Bioengineering Departments, and is also the Associate Director of the California NanoSystems Institute at UCLA.

Dr. Ozcan is elected Fellow of the National Academy of Inventors (NAI) and holds 40 issued patents and >20 pending patent applications for his inventions in telemedicine, mobile health, nanoscopy, wide-field imaging, lensless imaging, nonlinear optics, and fiber optics. Dr. Ozcan gave >50 plenary/keynote talks and >300 invited talks and is also the author of one book, the co-author of >700 publications in major scientific journals & conferences. Dr. Ozcan is the founder of Holomic/Cellmic LLC, which was named a Technology Pioneer by The World Economic Forum in 2015. Dr. Ozcan is also the Founder of Lucendi Inc.

Dr. Ozcan received several awards including the Presidential Early Career Award for Scientists and Engineers, International Commission for Optics (ICO) Prize, SPIE Biophotonics Technology Innovator Award, SPIE Early Career Achievement Award, ARO Young Investigator Award, NSF CAREER Award, NIH Director’s New Innovator Award, ONR Young Investigator Award, IEEE Photonics Society Young Investigator Award, and Distinguished Lecturer Award, as well as MIT’s TR35 Award.

Dr. Ozcan is also the recipient of the National Geographic Emerging Explorer Award, National Academy of Engineering The Grainger Foundation Frontiers of Engineering Award, Popular Science Brilliant 10 Award, Gates Foundation Grand Challenges Award, Popular Mechanics Breakthrough Award, Netexplorateur Award, Microscopy Today Innovation Award, the Wireless Innovation Award (Vodafone Americas Foundation) and the Okawa Foundation Award.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)